Pei-Cheng Lin results 175
· Newest (Page 1/7, per page 25)
Author: Pei-Cheng Lin ×Clear All Filters
Search Results
MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBCNARA Subscribed
Immunogenic cell death (ICD) can activate immune cells and potentiate the response to immunotherapy. The mitogen-activated protein kinase (MAPK) signaling pathway regulates the immune response and mediates T-cell receptor signaling. Activation of the MAPK signaling pathway decreases the levels of tumor-infiltrating lymphocytes in triple-negative breast cancer (TNBC) and is associated with worse survival. Here, we investigated...
Precision measurement of the Ds*+-Ds+ meson mass differenceNARA Subscribed
Multiprotein-based nanomedicines with dual CD44/CD133 targeting and GSH-responsive drug release for improving cancer chemotherapyNARA Subscribed
Albumin, a highly biocompatible protein, has been utilized in the construction of anti-cancer drugs for the treatment of various cancers. However, albumin-based nanomedicines still face several clinical challenges, including low stability in the bloodstream, non-specific targeting ability, and lack of controlled release capability. To address these limitations, we developed a multiprotein-based nanomedicine for targeted chemot...